{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:50:12Z","timestamp":1793235012672,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/jnci\/djx198","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T11:08:31Z","timestamp":1502968111000},"page":"290-303","source":"Crossref","is-referenced-by-count":51,"title":["Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma"],"prefix":"10.1093","volume":"110","author":[{"given":"Valentina","family":"Audrito","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, University of Turin, Italy"},{"name":"Italian Institute for Genomic Medicine, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Manag\u00f2","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, Italy"},{"name":"Italian Institute for Genomic Medicine, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"La Vecchia","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, Italy"},{"name":"Italian Institute for Genomic Medicine, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zamporlini","sequence":"additional","affiliation":[{"name":"Department of Agricultural, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Vitale","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnologies and Health Science, University of Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Baroni","sequence":"additional","affiliation":[{"name":"Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Cignetto","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, Italy"},{"name":"Italian Institute for Genomic Medicine, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Serra","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, Italy"},{"name":"Italian Institute for Genomic Medicine, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Bologna","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, Italy"},{"name":"Italian Institute for Genomic Medicine, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aureliano","family":"Stingi","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, Italy"},{"name":"Italian Institute for Genomic Medicine, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Arruga","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, Italy"},{"name":"Italian Institute for Genomic Medicine, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Vaisitti","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, Italy"},{"name":"Italian Institute for Genomic Medicine, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Massi","sequence":"additional","affiliation":[{"name":"Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Mandal\u00e0","sequence":"additional","affiliation":[{"name":"Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Raffaelli","sequence":"additional","affiliation":[{"name":"Department of Agricultural, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Deaglio","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, Italy"},{"name":"Italian Institute for Genomic Medicine, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,27]]},"reference":[{"issue":"2","key":"key\n\t\t\t\t20180314200246_djx198-B1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"key\n\t\t\t\t20180314200246_djx198-B2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrc3340","article-title":"The NAD metabolome\u2014a key determinant of cancer cell biology","volume":"12","author":"Chiarugi","year":"2012","journal-title":"Nat Rev Cancer."},{"issue":"6265","key":"key\n\t\t\t\t20180314200246_djx198-B3","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD(+) in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science."},{"issue":"13","key":"key\n\t\t\t\t20180314200246_djx198-B4","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2174\/092986711795590101","article-title":"NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism","volume":"18","author":"Burgos","year":"2011","journal-title":"Curr Med Chem."},{"issue":"9","key":"key\n\t\t\t\t20180314200246_djx198-B5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrendo.2015.117","article-title":"Physiological and pathophysiological roles of NAMPT and NAD metabolism","volume":"11","author":"Garten","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"key\n\t\t\t\t20180314200246_djx198-B6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2133.2011.10239.x","article-title":"Noninvasive genomic detection of melanoma","volume":"164","author":"Wachsman","year":"2011","journal-title":"Br J Dermatol."},{"issue":"1","key":"key\n\t\t\t\t20180314200246_djx198-B7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/pcmr.12037","article-title":"Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions","volume":"26","author":"Maldi","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"issue":"16","key":"key\n\t\t\t\t20180314200246_djx198-B8","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1021\/jm4001049","article-title":"Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors","volume":"56","author":"Galli","year":"2013","journal-title":"J Med Chem."},{"issue":"6","key":"key\n\t\t\t\t20180314200246_djx198-B9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2174\/1389450111314060003","article-title":"Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: Rationales, controversies, clinical experience","volume":"14","author":"Montecucco","year":"2013","journal-title":"Curr Drug Targets"},{"key":"key\n\t\t\t\t20180314200246_djx198-B10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pharmthera.2015.02.004","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer","volume":"151","author":"Sampath","year":"2015","journal-title":"Pharmacol Ther"},{"issue":"5","key":"key\n\t\t\t\t20180314200246_djx198-B11","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1074\/jbc.M112.394510","article-title":"Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: Metabolic basis and potential clinical implications","volume":"288","author":"Tan","year":"2013","journal-title":"J Biol Chem."},{"issue":"6892","key":"key\n\t\t\t\t20180314200246_djx198-B12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature."},{"issue":"9","key":"key\n\t\t\t\t20180314200246_djx198-B13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N Engl J Med."},{"issue":"26","key":"key\n\t\t\t\t20180314200246_djx198-B14","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med."},{"issue":"9839","key":"key\n\t\t\t\t20180314200246_djx198-B15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"key\n\t\t\t\t20180314200246_djx198-B16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1158\/2159-8290.CD-12-0012","article-title":"Circumventing cancer drug resistance in the era of personalized medicine","volume":"2","author":"Garraway","year":"2012","journal-title":"Cancer Discov."},{"issue":"18","key":"key\n\t\t\t\t20180314200246_djx198-B17","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med."},{"issue":"4","key":"key\n\t\t\t\t20180314200246_djx198-B18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/2159-8290.CD-13-0440","article-title":"Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis","volume":"4","author":"Parmenter","year":"2014","journal-title":"Cancer Discov."},{"issue":"3","key":"key\n\t\t\t\t20180314200246_djx198-B19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molmed.2014.12.007","article-title":"Molecular drivers of cellular metabolic reprogramming in melanoma","volume":"21","author":"Abildgaard","year":"2015","journal-title":"Trends Mol Med."},{"key":"key\n\t\t\t\t20180314200246_djx198-B20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.phrs.2016.02.009","article-title":"Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma","volume":"107","author":"Smith","year":"2016","journal-title":"Pharmacol Res."},{"issue":"2","key":"key\n\t\t\t\t20180314200246_djx198-B21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/onc.2016.198","article-title":"Metabolic rewiring in melanoma","volume":"36","author":"Ratnikov","year":"2017","journal-title":"Oncogene."},{"issue":"11","key":"key\n\t\t\t\t20180314200246_djx198-B22","doi-asserted-by":"crossref","first-page":"e113939","DOI":"10.1371\/journal.pone.0113939","article-title":"Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues","volume":"9","author":"Mori","year":"2014","journal-title":"PLoS One."},{"issue":"1","key":"key\n\t\t\t\t20180314200246_djx198-B23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1054","article-title":"High frequency of BRAF mutations in nevi","volume":"33","author":"Pollock","year":"2003","journal-title":"Nat Genet."},{"issue":"3","key":"key\n\t\t\t\t20180314200246_djx198-B24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","article-title":"Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF","volume":"23","author":"Haq","year":"2013","journal-title":"Cancer Cell."},{"issue":"3","key":"key\n\t\t\t\t20180314200246_djx198-B25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2012.11.020","article-title":"PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress","volume":"23","author":"Vazquez","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"key\n\t\t\t\t20180314200246_djx198-B26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2015.06.006","article-title":"Metabolic reprogramming supports the invasive phenotype in malignant melanoma","volume":"366","author":"Bettum","year":"2015","journal-title":"Cancer Lett."},{"issue":"9","key":"key\n\t\t\t\t20180314200246_djx198-B27","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bbapap.2015.02.021","article-title":"Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues","volume":"1854","author":"Ruggieri","year":"2015","journal-title":"Biochim Biophys Acta."},{"issue":"22","key":"key\n\t\t\t\t20180314200246_djx198-B28","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1111\/febs.13050","article-title":"Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD(+) biosynthetic machinery in mammalian cells","volume":"281","author":"Zamporlini","year":"2014","journal-title":"FEBS J."},{"issue":"2","key":"key\n\t\t\t\t20180314200246_djx198-B29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1677\/jme.0.0260107","article-title":"Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes","volume":"26","author":"Ognjanovic","year":"2001","journal-title":"J Mol Endocrinol."},{"issue":"7","key":"key\n\t\t\t\t20180314200246_djx198-B30","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/art.21942","article-title":"Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: Implications in the pathogenesis of rheumatoid arthritis","volume":"54","author":"Nowell","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"11","key":"key\n\t\t\t\t20180314200246_djx198-B31","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s00125-009-1509-2","article-title":"Extracellular PBEF\/NAMPT\/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity","volume":"52","author":"Romacho","year":"2009","journal-title":"Diabetologia."},{"issue":"9","key":"key\n\t\t\t\t20180314200246_djx198-B32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","article-title":"MITF: Master regulator of melanocyte development and melanoma oncogene","volume":"12","author":"Levy","year":"2006","journal-title":"Trends Mol Med."},{"issue":"7","key":"key\n\t\t\t\t20180314200246_djx198-B33","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00018-014-1791-0","article-title":"MITF in melanoma: Mechanisms behind its expression and activity","volume":"72","author":"Hartman","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"1\u20132","key":"key\n\t\t\t\t20180314200246_djx198-B34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11010-011-0823-4","article-title":"Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors","volume":"354","author":"Wan","year":"2011","journal-title":"Mol Cell Biochem."},{"issue":"10","key":"key\n\t\t\t\t20180314200246_djx198-B35","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/ncb2324","article-title":"NF-kappaB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration","volume":"13","author":"Mauro","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"1","key":"key\n\t\t\t\t20180314200246_djx198-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem J."},{"issue":"4","key":"key\n\t\t\t\t20180314200246_djx198-B37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.devcel.2010.02.013","article-title":"Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis","volume":"18","author":"Gavet","year":"2010","journal-title":"Dev Cell."},{"issue":"34","key":"key\n\t\t\t\t20180314200246_djx198-B38","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1038\/sj.onc.1207757","article-title":"Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells","volume":"23","author":"Yuan","year":"2004","journal-title":"Oncogene."},{"issue":"9","key":"key\n\t\t\t\t20180314200246_djx198-B39","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1074\/jbc.M115.683052","article-title":"Thromboxane A2 receptor inhibition suppresses multiple myeloma cell proliferation by inducing p38\/c-jun N-terminal kinase (JNK) mitogen-activated protein kinase (MAPK)-mediated G2\/M progression delay and cell apoptosis","volume":"291","author":"Liu","year":"2016","journal-title":"J Biol Chem."},{"issue":"2","key":"key\n\t\t\t\t20180314200246_djx198-B40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.devcel.2014.03.012","article-title":"Cyclin B1\/Cdk1 coordinates mitochondrial respiration for cell-cycle G2\/M progression","volume":"29","author":"Wang","year":"2014","journal-title":"Dev Cell."},{"issue":"1","key":"key\n\t\t\t\t20180314200246_djx198-B41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood-2014-07-589069","article-title":"Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia","volume":"125","author":"Audrito","year":"2015","journal-title":"Blood"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/110\/3\/290\/24280932\/djx198.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:03:06Z","timestamp":1521072186000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/110\/3\/290\/4259433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,27]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,9,27]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djx198","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,9,27]]}}}